MUNIN CORP has a total of 36 patent applications. Its first patent ever was published in 1997. It filed its patents most often in United States, Australia and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, pharmaceuticals and agriculture are AXON NEUROSCIENCE, DAVID GLADSTONE INST J and CARTELA AB.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | Australia | 7 | |
#3 | EPO (European Patent Office) | 6 | |
#4 | China | 3 | |
#5 | Hong Kong | 3 | |
#6 | Israel | 3 | |
#7 | Canada | 2 | |
#8 | Taiwan | 2 | |
#9 | WIPO (World Intellectual Property Organization) | 2 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Agriculture | |
#4 | Measurement |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Animal care | |
#3 | Microorganisms | |
#4 | Analysing materials | |
#5 | Medical preparations | |
#6 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Lau Lester F | 28 |
#2 | Yeung Cho-Yau | 12 |
#3 | Greenspan Jeffrey A | 8 |
#4 | Hsu Li-Chung | 4 |
#5 | Liu Shu | 4 |
#6 | Lau L F | 1 |
#7 | Greenspan J A | 1 |
#8 | Cho-Yau Yeung | 1 |
Publication | Filing date | Title |
---|---|---|
US2009081228A1 | Cyr61 compositions and methods | |
AU2007242926A1 | Extracellular matrix signalling molecules | |
EP1718965A2 | Ccn1 transgenic animals | |
WO2005040191A2 | Ccn1 compositions and methods | |
AU2004202578A1 | Extracellular matrix signalling molecules | |
WO2004090109A2 | Ccn3 compositions and methods | |
AU2003220274A1 | Cloning and characterization of g+c-rich promoter binding protein | |
AU3504901A | Extracellular matrix signalling molecules | |
CA2398660A1 | Human cyr61 | |
US7521540B2 | CYR61 compositions and methods | |
EP1892250A2 | CYR61 compositions and methods | |
US6790606B1 | Extracellular matrix signaling molecules | |
EP0888452A2 | Human cyr61, an extracellular matrix signalling molecule |